The stock of Clorox Co (NYSE:CLX) hit a new 52-week low and has $106.18 target or 7.00% below today’s $114.17 share price. The 5 months bearish chart indicates high risk for the $14.79B company. The 1-year low was reported on Nov, 3 by Barchart.com. If the $106.18 price target is reached, the company will be worth $1.04 billion less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 528,562 shares traded hands. Clorox Co (NYSE:CLX) has declined 9.19% since April 1, 2016 and is downtrending. It has underperformed by 10.41% the S&P500.
Analysts await Clorox Co (NYSE:CLX) to report earnings on November, 7. They expect $1.42 EPS, up 7.58% or $0.10 from last year’s $1.32 per share. CLX’s profit will be $183.95M for 20.10 P/E if the $1.42 EPS becomes a reality. After $1.26 actual EPS reported by Clorox Co for the previous quarter, Wall Street now forecasts 12.70% EPS growth.
Clorox Co (NYSE:CLX) Ratings Coverage
Out of 9 analysts covering The Clorox Company (NYSE:CLX), 1 rate it a “Buy”, 4 “Sell”, while 4 “Hold”. This means 11% are positive. The Clorox Company has been the topic of 17 analyst reports since August 5, 2015 according to StockzIntelligence Inc. On Friday, February 26 the stock rating was downgraded by Sterne Agee CRT to “Neutral”. The stock has “Underweight” rating given by Barclays Capital on Wednesday, October 7. Deutsche Bank maintained it with “Hold” rating and $114 target price in Wednesday, August 5 report. The firm has “Buy” rating given on Friday, September 16 by Atlantic Securities. The stock of Clorox Co (NYSE:CLX) has “Buy” rating given on Tuesday, July 21 by Sterne Agee CRT. Barclays Capital maintained the shares of CLX in a report on Monday, March 21 with “Underweight” rating. UBS maintained the stock with “Sell” rating in Tuesday, November 3 report. The firm has “Neutral” rating given on Tuesday, June 14 by Atlantic Securities. The firm has “Hold” rating given on Tuesday, November 3 by Deutsche Bank. JP Morgan maintained Clorox Co (NYSE:CLX) rating on Wednesday, May 4. JP Morgan has “Underweight” rating and $123 price target.
According to Zacks Investment Research, “Clorox Company’s business operations, represented by the aggregate of its U.S. Household Products and Canada, U.S. Specialty Products and International segments, include the production and marketing of non-durable consumer products sold primarily through grocery and other retail stores.”
Insitutional Activity: The institutional sentiment decreased to 0.98 in 2016 Q2. Its down 0.12, from 1.1 in 2016Q1. The ratio turned negative, as 66 funds sold all Clorox Co shares owned while 246 reduced positions. 49 funds bought stakes while 256 increased positions. They now own 87.29 million shares or 6.63% less from 93.49 million shares in 2016Q1.
Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 21,174 shares or 0.04% of the stock. Cypress Asset Management Tx accumulated 0.16% or 5,900 shares. Moreover, Fmr Ltd has 0% invested in Clorox Co (NYSE:CLX) for 95,663 shares. Alexandria Capital Ltd Liability Corporation has 0% invested in the company for 49 shares. Finemark Comml Bank And Tru, a Florida-based fund reported 845 shares. Bkd Wealth Advsr Ltd Liability last reported 0.09% of its portfolio in the stock. Jpmorgan Chase & last reported 0.01% of its portfolio in the stock. Moreover, Bragg Fin Advisors Inc has 0.25% invested in Clorox Co (NYSE:CLX) for 9,911 shares. Anchor Advsrs Ltd Llc owns 224,119 shares or 0.79% of their US portfolio. Parsec Mngmt accumulated 1,557 shares or 0.02% of the stock. Benin Mngmt Corp last reported 0.11% of its portfolio in the stock. Bbva Compass Bancshares Incorporated accumulated 3,507 shares or 0.04% of the stock. Moreover, Duncker Streett & Inc has 0.12% invested in Clorox Co (NYSE:CLX) for 2,400 shares. Dumont & Blake Advsrs Ltd, a New Jersey-based fund reported 2,066 shares. Edge Asset has 0.01% invested in the company for 10,053 shares.
Insider Transactions: Since May 10, 2016, the stock had 0 insider buys, and 5 selling transactions for $7.59 million net activity. The insider Balousek Jon M sold 5,136 shares worth $673,517. Vlahos Nikolaos A had sold 925 shares worth $123,093. $5.12M worth of shares were sold by STEIN LAURA on Friday, September 2. Willoughby Dawn C had sold 10,617 shares worth $1.39M.
More news for Clorox Co (NYSE:CLX) were recently published by: Investorplace.com, which released: “Can Clorox Co Stock Get Back on Track? (CLX)” on October 25, 2016. Investorplace.com‘s article titled: “Stocks to Buy: Colgate-Palmolive Corporation & Clorox Co Shine (CL, CLX)” and published on October 05, 2016 is yet another important article.
CLX Company Profile
The Clorox Company, incorporated on September 5, 1986, is a maker and marketer of consumer and professional products. The Firm sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Firm operates through four divisions: Cleaning, Household, Lifestyle and International. The Firm markets some of the consumer brand names, including namesake bleach and cleaning products, Pine-Sol cleaners, Liquid-Plumr clog removers, Poett home care products, Fresh Step cat litter, Glad bags, wraps and containers, Kingsford charcoal, Hidden Valley dressings and sauces, Brita water-filtration products and Burt’s Bees natural personal care products. The Firm also markets brands for professional services, including Clorox Healthcare and Clorox Commercial Solutions. The Firm makes products in approximately 10 countries and markets them in over 100 countries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.